Multiple myeloma can feel unfamiliar and overwhelming at first, but today’s advances tell a much brighter story.
In this episode, Dr. Andrew Yee of Massachusetts General Hospital explains what myeloma is, how it’s diagnosed, and why new treatment options, from four-drug regimens to CAR T-cell therapy and bispecific antibodies, are transforming patient outcomes. With enthusiasm and relatable analogies, he highlights how patients may progress from periods of significant challenges to reaching a level of stability and well‑being that allows them to live fully. This conversation offers clarity, confidence, and real optimism for anyone navigating myeloma.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Multiple myeloma
- Amyloidosis
- Autologous stem cell transplantation
- CAR T-cell therapy
- Immunotherapy fact sheet
- Clinical Trial Support Center
Additional Blood Cancer United Support Resources:
- Information Specialists
- Financial support
- Online Chat
- Free Nutrition Consultations
- Free telephone/web patient programs
- Free booklets
- Young Adult Resources
- Support groups
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Advocacy and Public Policy
- Patient Community
- Mental Health Resources
Episode supported by AbbVie Inc.; Bristol Myers Squibb; Genentech, A Member of the Roche Group; GSK plc.; Johnson & Johnson.